Studie & opleiding
- 1987-1993: Studie Geneeskunde Erasmus Universiteit Rotterdam
- 1995: Artsexamen Erasmus Universiteit Rotterdam
- 1996-1997: Opleiding tot militair-arts, eerste luitenant Geneeskundige Dienst
- 2000 – 2005: Opleiding tot internist Deventer Ziekenhuis en Universitair Medisch Centrum Groningen
- 2005-2006: Opleiding tot intensivist Universitair Medisch Centrum Groningen
- 2006: European Diploma in Intensive Care Medicine (EDIC) I + II
- 2006-heden: Internist-intensivist in Elisabeth-Tweesteden Ziekenhuis
- 2023: Doctor of Philosophy (PhD) Vrije Universiteit Amsterdam
Lidmaatschappen
- Nederlandse Internisten Vereniging (NIV)
- Nederlandse Vereniging voor Intensive Care (NVIC)
- European Society of Intensive Care Medicine (ESICM)
Onderzoek & publicaties
1: Pelikan Z, van Oers JA, Levens WJL, Fouchier SM. De rol van allergie bij interstitiële cystitis. Ned Tijdschr Geneeskd. 1999; 143:1289-92.
2: van Oers JA, Ponssen HH, Hesp WL. Pneumopericardium, pneumomediastinum, pericarditis and mediastinal abscess secondary to diverticulitis of the sigmoid. Intensive Care Med. 2000; 26:1867-8.
3: van Oers JA, de Leeuw J, van Bommel EF. Nephrotic syndrome associated with isotretinoin. Nephrol Dial Transplant. 2000; 15:923-4.
4: Ponssen H, van Oers J, Hesp F. A connection between the abdominal space and the mediastinum. Crit Care Med. 2002; 30:1182.
5: van Oers JA, Roeloffzen WW, van der Werf TS. Pneumothorax? Neth J Med. 2005; 63:322, 336.
6: van Oers JA, Tulleken JE, Ligtenberg JM, Meertens JHJM, Zijlstra JG. Can procalcitonin guide therapy in newly admitted critically ill patients? Neth J Crit Care. 2007; 11:81-6.
7: van Oers JA, Tulleken JE, Zijlstra JG. Does serum procalcitonin have a diagnostic value in febrile adult patients presenting to the emergency department? Crit Care. 2007; 11:422.
8: Mungra RAA, Croonen A, Speelberg A, van Oers JAH. Sepsis and ARDS due to actinomycosis and fusobacterium nucleatum associated with intrauterine contraceptive device. Neth J Crit Care. 2007; 11:198-9.
9: Lo-Ten-Foe JR, van Oers JA, Kotsopoulos AM, Buiting AG. Pulmonary colonization with Salmonella enterica serovar Kentucky in an intensive care unit. J Hosp Infect. 2007; 67:105-7.
10: van Oers JAH, Lo-Ten-Foe JR, Buiting AGM, Kotsopoulos AMM. A fatal complication of acute pharyngitis. Neth J Crit Care. 2008; 12:65-66.
11: Aerts MB, Vandevivere YDI, Beute GN, van Oers JAH. A subarachnoid haemorrhage as a complication of bacterial endocarditis. Neth J Crit Care. 2010; 14:32-5.
12: Fung TY, van de Kley SCJ, Frijlink DW, Brekelmans GFJ, van Oers JAH. Staphylococcus aureus endocarditis met cerebrale complicaties. A&I. 2010; 1:39-45.
13: van de Loo EEAJ, Oldenbeuving AW, Marcelis JH, van Oers JAH. Gegeneraliseerde tetanus bij een 65-jarige man met slikklachten, pijn in de nek en trismus na stap in een spijker. A&I. 2011; 3:38-43.
14: Vrijsen BEL, Kotsopoulos AMM, Vandevivere YDI, van Oers JAH. Negative pressure pulmonary oedema: a rare complication of anaesthesia. Neth J Crit Care 2012; 16:55-7.
15: Scheepers R, Ramnarain D, van Oers JAH. Ernstig schedelhersenletsel met verhoogde intracraniële druk. A&I, 2012 ;1:33-8.
16: Assink-de Jong E, de Lange DW, van Oers JA, Nijsten MW, Twisk JW, Beishuizen A. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomized prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients–calculated sample size: 1816 patients. BMC Infect Dis. 2013; 13:178.
17: Jansen D, van de Berg R, Bosman G, Vos P, van Oers JAH. Influenza A or B virus infection 2012-2013: incidence, characteristics and outcome in critically ill patients in 2 Dutch intensive Care units. Neth J Crit Care 2014; 18:11-4.
18: de Jong E, van Oers JA Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016; 16:819-27.
19: de Jong E, van Oers JA, Beishuizen A, Girbes AR, Nijsten MW, de Lange DW. Procalcitonin to guide antibiotic stewardship in intensive care – Authors’reply. Lancet Infect Dis. 2016; 16:889-90.
20: van Rosmalen J, van Oers JA. Een man met groene urine na een val van de trap. Ned Tijdschr Geneeskd. 2016; 160:D585.
21: van Oers JA, Nijsten MW, Girbes AR. Procalcitonin-Guided Antimicrobial Therapy-All About the Algorithm. JAMA Intern Med. 2017; 177:142.
22: van Oers JAH, de Jong E, Beishuizen A, Nijsten MW, Girbes AR, de Lange DW. Is a Single Initial Procalcitonin Test Sufficient in Septic, Critically Ill Patients to Minimize Antibiotic Use? Chest. 2017; 152:218-9.
23: Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Bhatnagar N, Annane D, Reinhart K, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Lima SS, Maravić-Stojković V, Verduri A, Cao B, Shehabi Y, Beishuizen A, Jensen JS, Corti C, van Oers JA, Falsey AR, de Jong E, Oliveira CF, Beghe B, Briel M, Mueller B. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017; 10:CD007498.
24: Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bucher HC, Annane D, Reinhart K, Falsey AR, Branche A, Damas P, Nijsten M, de Lange DW, Deliberato RO, Oliveira CF, Maravić-Stojković V, Verduri A, Beghé B, Cao B, Shehabi Y, Jensen JS, Corti C, van Oers JAH, Beishuizen A, Girbes ARJ, de Jong E, Briel M, Mueller B. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018; 18:95-107.
25: van Oers JAH, Nijsten MW, de Lange DW. Do we need new trials of procalcitonin-guided antibiotic therapy? A response. Crit Care. 2018; 22:83.
26: van Vught AJAH, van den Brink GTWJ, Hilkens MGEC, van Oers JAH. Analysis of the level of clinical skills of physician assistants tested with simulated intensive care patients. J Eval Clin Pract. 2018; 24:580-4.
27: Wirz Y, Meier MA, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Schroeder S, Nobre V, Annane D, Reinhart K, Damas P, Nijsten M, Shajiei A, deLange DW, Deliberato RO, Oliveira CF, Shehabi Y, van Oers JAH, Beishuizen A, Girbes ARJ, de Jong E, Mueller B, Schuetz P. Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit Care. 2018; 22:191.
28: Kip MMA, van Oers JA, Shajiei A, Beishuizen A, Berghuis AMS, Girbes AR, de Jong E, de Lange DW, Nijsten MWN, IJzerman MJ, Koffijberg H, Kusters R. Cost-effectiveness of procalcitonin testing to guide antibiotic treatment duration in critically ill patients: results from a randomised controlled multicentre trial in the Netherlands. Crit Care. 2018; 22:293.
29: Putker AE, van Oers JAH. Een man met acuut subcutaan emfyseem. Ned Tijdschr Geneeskd. 2019; 163:D3561.
30: van Oers JAH, Nijsten MW, de Jong E, Beishuizen A, de Lange DW. Why would procalcitonin perform better in patients with a SOFA-score less than 8? Int J Infect Dis. 2019; 89:185-186.
31: van Oers JAH, de Jong E, Kemperman H, Girbes ARJ, de Lange DW. Diagnostic Accuracy of procalcitonin and C-reactive Protein is insufficient to predict proven infection: a retrospective cohort study in critically ill patients fulfilling the sepsis-3 criteria. J Appl Lab Med. 2020; 5:62-72.
32: Murk JL, van de Biggelaar R, Stohr J, Verweij J, Buiting A, Wittens S, van Hooft M, Diederen B, Kluiters-de Hingh Y, Ranschaer E, Brouwer A, Retera J, Verheijen M, Ramnarain D, van Ek I, van Oers J. De eerste honderd opgenomen COVID-19-patiënten in het Elisabeth-Tweesteden Ziekenhuis. Ned Tijdschr Geneeskd. 2020; 164:D5002
33: Heilmann E, Gregoriano C, Wirz Y, Luyt CE, Wolff M, Chastre J, Tubach F, Christ-Crain M, Bouadma L, Annane D, Damas P, Kristoffersen KB, Oliveira CF, Stolz D, Tamm M, de Jong E, Reinhart K, Shehabi Y, Verduri A, Nobre V, Nijsten M, deLange DW, van Oers JAH Beishuizen A, Girbes ARJ, Mueller B, Schuetz P. Association of kidney function with effectiveness of procalcitonin-guided antibiotic treatment: a patient-level meta-analysis from randomized controlled trials. Clin Chem Lab Med. 2020; 59:441-53.
34: Vogels Y, Pouwels S, van Oers J, Ramnarain D. Characteristics and risk factors associated with mortality in critically ill patients with COVID-19. Cureus. 2021; 13:e14442.
35: van Oers J, Krabbe J, Kemna E, Kluiters Y, Vos P, de Lange D, Girbes A, Beishuizen A. Mid-regional proadrenomedullin and mid-regional proatrial natriuretic peptide clearance predicts poor outcomes better than single baseline measurements in critically ill patients with pneumonia: a retrospective cohort study. Cureus. 2021; 13:e15285.
36: Vanderbeke L, Janssen NAF, Bergmans DCJJ, Bourgeois M, Buil JB, Debaveye Y, Depuydt P, Feys S, Hermans G, Hoiting O, van der Hoven B, Jacobs C, Lagrou K, Lemiale V, Lormans P, Maertens J, Meersseman P, Mégarbane B, Nseir S, van Oers JAH, Reynders M, Rijnders BJA, Schouten JA, Spriet I, Thevissen K, Thille AW, Van Daele R, van de Veerdonk FL, Verweij PE, Wilmer A, Brüggemann RJM, Wauters J; Dutch-Belgian Mycosis Study Group. Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial. Intensive Care Med. 2021; 47:674-86.
37: Pouwels S, Ramnarain D, Aupers E, Rutjes-Weurding , van Oers J. Obesity may not be associated with 28-day mortality, duration of invasive mechanical ventilation and length of intensive care unit and hospital stay in critically ill patients with severe acute respiratory syndrome coronavirus-2: a retrospective cohort study. Medicina. 2021; 57:674.
38: Wilting FNH, Kotsopoulos AMM, Platteel ACM, van Oers JAH. Intracerebral hemorrhage and thrombocytopenia after AstraZeneca COVID-19 vaccine: clinical and diagnostic challenges of vaccine-induced thrombotic thrombocytopenia. Cureus. 2021; 13:e17637.
39: Heilmann E, Gregoriano C, Annane D, Reinhart K, Bouadma L, Wolff M, Chastre J, Luyt CE, Tubach F, Branche AR, Briel M, Christ-Crain M, Welte T, Corti C, de Jong E, Nijsten M, de Lange DW, van Oers JAH, Beishuizen A, Girbes ARJ, Deliberato RO, Schroeder S, Kristoffersen KB, Layios N, Damas P, Lima SSS, Nobre V, Wei L, Oliveira CF, Shehabi Y, Stolz D, Tamm M, Verduri A, Wang JX, Drevet S, Gavazzi G, Mueller B, Schuetz P. Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials. Age Ageing. 2021; 50:1546-56.
40: Klijn A, Valk L, van Oers JAH. A subarachnoid haemorrhage heralding bacterial endocarditis. Neth J Crit Care. 2021; 29:258-61.
41: van Oers JAH, Kluiters Y, Bons JAP, de Jongh M, Pouwels S, Ramnarain D, de Lange DW, de Grooth HJ, Girbes ARJ. Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study. J Crit Care. 2021; 66:173-80.
42: van Oers JAH, de Grooth HJ, de Lange DW, Girbes ARJ. Response to: MR-proADM has a good ability to predict mortality in critically ill patients with SARS-CoV-2 pneumonia: Beware of some potential confounders! J Crit Care. 2022; 67:214-5.
43: van Oers JAH, Ramnarain D, Oldenbeuving A, Vos P, Roks G, Kluiters Y, Beishuizen A, de Lange DW, de Grooth HJ, Girbes ARJ. C-terminal proarginine vasopressin is associated with disease outcome and mortality, but not with delayed cerebral ischemia in critically ill patients with an aneurysmal subarachnoid hemorrhage: a prospective cohort study. Neurocrit Care. 2022; 37:678-88.
44: van Oers JAH, Pouwels S, Ramnarain D, Kluiters Y, Bons JAP, de Lange DW, de Grooth HJ, Girbes ARJ. Mid-regional proadrenomedullin and C-terminal proendothelin -1 values, and disease course are not different in critically ill SARS-CoV-2 pneumonia patients with obesity. Int J Obes. 2022; 46:1801-7.
45: op ’t Hoog SAJJ, Eskes AM, van Oers JAH, Boerrigter JL, Prins-Smulders MWJC, Oomen M, van der Hoeven JG, Vermeulen H, Vloet LCM. A quality improvement project to support post-intensive care unit patients with COVID-19: structured telephone support. Int J Environ Res Public Health. 2022; 19:9689.
46: Shajiei A, Berends MS, Luz CF, van Oers JA, Harmsen HJM, Vos P, Klont R, Loef BG, Reidinga AC, Bormans-Russell L, Linsen K, Dormans T, Otten M, van der Bij A, Beishuizen A, de Lange DW, de Jong E, Nijsten MW. Impact of reduced antibiotic treatment duration on antimicrobial resistance in critically ill patients in the randomized controlled SAPS-trial. Front Med. 2023; 10:1080007.
47: van Oers JAH, Workum JD, Voorzaat BM, Jaspers TCC. Pharmacokinetics of amphotericin B after accidental overdose in an adult critically ill patient treated with plasmapheresis: a case report and review of literature. Int J Basic Clin Pharmacol 2024; 13:276-9.
